Matches in Nanopublications for { ?s ?p "[New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP376721.RAuuWRFSgDGfycOMSEMVBR6UVUQwxgfFhTeDPSFB8vWfQ130_assertion description "[New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376721.RAuuWRFSgDGfycOMSEMVBR6UVUQwxgfFhTeDPSFB8vWfQ130_provenance.
- assertion description "[New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_assertion description "[New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645855.RARfKTD-fYZMQ8wPIf41pc1XZG3n73E_K_hYULXRTQq8w130_provenance.
- assertion description "[New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_assertion description "[New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979966.RAqnDnF5gz1kZF0aSyO1wKW3w2K5JvVl_qNdl237xwtrs130_provenance.
- NP979969.RAOL_S3sIw-zm1oD0jQDbfB9KQGiqnSaPErvjoAltsG4A130_assertion description "[New, highly selective inhibitors of BRAF and MEK1/2 have shown promise in clinical trials, including in previously intractable diseases such as melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979969.RAOL_S3sIw-zm1oD0jQDbfB9KQGiqnSaPErvjoAltsG4A130_provenance.